In recent years, transplantation has assumed an important role in the treatment of patients with end-stage organ failure. With the passage of Transplantation of Human Organ Act by the Indian parliament, transplantation of organs from brain dead donors has become a reality. Although there are many issues in success of cadaver programme, intensivists can play a crucial role by converting a potential donor into an actual donor. This article reviews the identification of potential organ donor and pathophysiological changes surrounding brain death, with particular emphasis on management of the organ donor in the intensive care unit. With an increased awareness of donor management issues and the application of a rational physiological approach, the number of functional organs for transplantation can be increased.
Shankrakumar U. Human leucocyte antigen matching and cadaver renal transplantation in India. Br J Biomed Sci 2001;58:255.
Wight C, Cohen B. Organ shortages: Maximizing the donor potential. Br Med Bull 1997;53:817-28.
The potential of Indian cadaver transplantation programme in India- Editorial. Indian Transplant Newsletter 2005;6:3.
Shroff S, Navin S, Abraham G, Rajan PS, Suresh S, Rao S, et al. Cadaver organ donation and transplantation - Indian perspective. Transplant Proc 2003;35:15-7.
Mishra MN, Saxena VK, Narula AS. Differences in renal transplantation in India. Int J Hum Genet 2004;4:161-5.
Lopez-Navidad A, Caballero F. Extended criteria for organ acceptance- Strategies for achieving organ safety and for increasing donor pool. Clin Transplant 2003;17:308-24.
Hayek D, Veremakis C, O′Brein JA. Time-dependent characteristics of hemodynamic instability in brain dead organ donors. Crit Care Med 1990;18:S204.
Hung TP, Chen ST. Prognosis of deeply comatose patients on ventilators. J Neurol Neurosurg Psychiatr 1995;58:75-80.
Shivalkar B, VanLoon J, Wieland W, Tjandra-Maga TB, Borgers M, Plets C, et al. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation 1993;87:230-9.
Power BM, Van Heerden PV. The physiological changes associated with brain death:current concepts and implications for the treatment of the brain dead organ donor. Anaesth Intens Care 1995;23:26-36.
Guidelines for Adult Organ Donation. Intensive Care Society′s Working Group on Organ and Tissue Donation 2004.
Tropmann C, Dunn DL. Management of the organ donor. 5th ed. Irwin and Ripple′s Intensive Care Medicine. 2184-201.
Karcioglu O, Ayrik C, Erbil B. The brain-dead patient or a flower in the vase? The emergency department approach to the preservation of the organ donor. Eur J Emergency Med 2003;10:52-7.
Jenkins DH, Reilly PM, Schwab CW. Improving the approach to organ donation: a review. World J Surg 1999;23:644-9.
Zaroff JG, Rosengard BR, Armstrong WF, et al. Consensus conference report:maximizing use of organs recovered from the cadaver donor; cardiac recommendations. Circulation 2002;106:836-41.
Braunfeld MY. Cadaveric donors. Anaesthesiol Clin North Am 2004;22:615-31.
Goldberg LL. Cardiovascular and renal actions of dopamine. Potential clinical applications. Pharmacol Rev 1992;24:1-29.
Scheinkestel CD, Tuxen DV, Cooper DJ, Butt W. Medical management of the (potential) organ donor. Anaesth Intens Care 1995;23:51-9.
Chen JM, Cullinane S, Spanier TB, Artrip JH, John R, Edwards NM, et al. Vasopressin deficiency and pressor hypersensitivity in haemodynamically unstable organ donors. Circulation 1999;100:244-6.
Kinoshita Y, et al. Long term renal preservation after brain death maintained with vasopressin and epinephrine. Transplant Intl 1990;3:15-8.
Novitzky D. Donor management: State of the art. Transplant Proc 1997;29:3773-5.
Vaghadia H. Atropine resistance in brain dead organ donors. Anesthesiology 1986;65:711-712.
Neumann T, Post H, Ganz RE, et al. Linear and nonlinear dynamics of heart-rate variability in brain dead organ donors. Z Kardio 2001;90:484-91.
Nygaard CE, Townsend RN, Diamond DL. Organ donor management and organ outcome: A 6-year review from a level I trauma center. J Trauma 1990;30:728-32.
Power DJ, Darby JM, Stuart SA. Recommendations for mechanical ventilation during donor care. Prog Transplant 2000;10:33-8.
Rogers FB, Shackford SR, Trevisani GT, Davis JW, Mackersie RC, Hoyt DB. Neurogenic pulmonary oedema in fatal and nonfatal head injuries. J Trauma 1995;39:860-7.
Power DJ, Kellum JA. Maintaining acidbase balance in organ donors. Prog Transplant 2000;10:98-103.
Ramos HC, Lopez R. Critical care management of the brain-dead organ donor. Current Opinion in Organ Transplantation 2002;7:70-5.
Debelak L, Pollak R, Reckard C. Arginine vasopressin versus desmopressin in the treatment of diabetes insipidus in the brain dead organ donor. Transplant Proc 1990;22:351.
Totsuka E, Dodson F, Urakami AI, Moras N, Ishii T, Lee MC, et al. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: Effects of correction of donor hypernatremia. Liver Transpl Surg 1999;5:421-8.
Masson F, Thicoipe M, Gin H, DeMascarel A, Angibeau RM, Favarel-Garrigues J, et al. The endocrine pancreas in brain-dead donors. Transplantation 1993:56:363-7.
Gramm HJ, Meinhold H, Bickel U, Zimmermann J, von Hammerstein B, Keller F, et al. Acute endocrine failure after brain death? Transplantation 1992;54:851-7.
Howlett TA, Keogh AM, Perry L, Touzel R, Rees LH. Anterior & posterior pituitary function in brain-stem-dead donors: A possible role for hormonal replacement therapy. Transplantation 1989;47:828-34.
Arita K, Uozumi T, Oki S, Kurisu K, Ohtani M, Mikami T. The function of the hypothalamo-pituitary axis in brain-dead patients. Acta Neurochir (Wien) 1993;123:64-75.
Randell TT, Hockerstedt KA. Triiodothyronine treatment in brain-dead multiorgan donors: a controlled study. Transplantation 1992;54:736-8.
Randell TT, Hockerstedt KA. Triiodothyronine treatment is not indicated in brain-dead multiorgan donors: A controlled study. Transplant Proc 1993;25:1552-3.
Goarin JP, Cohen S, Riou B, Jacquens Y, Guesde R, Le Bret F, et al. The effects of triiodothyronine on haemodynamic status and cardiac function in potential heart donors. Anesth Analg 1996;83:41-7.
Rosendale JD, Kauffman HM, McBride MA. Hormonal replacement therapy yields more transplanted hearts with improved early function. Transplantation 2003;75:1336-41.
Rosendale JD, Kauffman HM, McBride MA, Chabalewski FL, Zaroff JG, et al. Aggressive pharmacological donor management results in more transplanted organs. Transplantation 2003;75:482-7.
Wood KE, Becker BN, McCartney JG, D′Alenssandro AM, Coursin DB. Care of the potential organ donor. NEJM 2004;351:2730-9.
Hefty TR, Cotterell LW, Fraser SC, Goodnight SH, Hatch TR. Disseminated intravascular coagulation in cadaveric organ donors: Incidence and effect on renal transplantation. Transplantation 1993;55:442-3.
Razek T, Olthoff K, Reilly PM. Issues in potential organ donor management. Surg Clin North Am 2000;80:1021-32.
Kusaka M, Pratschke J, Wilhelm MJ, Ziai F, Zandi-Nejad K, Mackenzie HS, et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000;69:405-10.
Jassem W, Koo DD, Cerundolo L, Rela M, Heaton ND, Fuggle SV. Leucocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation 2003;75:2001-7.
Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998;17:423-9.
Theis JC, Teklote J, Clauer U, Tox U, Klar L, Hofmann WJ, et al. The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation. Transplant International 1988;11:S390-2.
Pratschke J, Kofla G, Wilhelm MJ, Vergopoulos A, Laskowski I, Shaw GD, et al. Improvements in early behavior of rat kidney allografts after treatment of the brain-dead donor. Ann Surg 2001;234:732-40.
Gelb AW, Robertson KM. Anaesthetic management of the brain dead for organ donation. Can J Anaesth 1990;37:806-12.
